@myesmo.bsky.socialESMO Fellowship session at #ESMO26: stories, perspectives, hopes and reflections from past and present fellows. A unique source of inspiration for #YoungOncologists.
đź”— https://ow.ly/n7IX50ZXGhR
#ESMOFellowships #CareerDevelopment
@myesmo.bsky.socialOne week to go until #ESMO26
Share your research or clinical highlights and key takeaways with the #OncologyCommunity.
Use #ESMO26 in your posts to be part of the scientific conversation and connect with colleagues from around the world.
@foundationmedicine.bsky.socialJoin Foundation Medicine at #ESMO26! Our team looks forward to engaging with the international oncology community on the latest research advancing precision medicine and oncology care.
@myesmo.bsky.socialWhy attend the ESMO Clinical Practice Guidelines Session at #ESMO26?
“It helps you put guidelines into clinical context and make them relevant to your practice.” Sanjay Popat
📆Add it to your agenda: https://ow.ly/Ai1E50ZXTtJ
@cdr-life.bsky.socialCDR-Life is heading to #ESMO26 in Madrid, Oct. 23–27! CEO Christian Leisner, CMO Dimitrios Chondros, MD, and colleagues look forward to discussing progress across our T cell engager pipeline, including CDR404 and CDR609.
Attending? Reach out to schedule a meeting!
@rodrigolastra.bsky.socialOn October 23, in #ESMO26 congress, I'll participate in the international #CSO meeting.
🌍 We will share initiatives and experiences from various countries...
If you are interested on @csoncol.bsky.social
commonsenseoncology.org
... register here!!:
@helloeacr.bsky.socialAttending this year's ESMO - European Society for Medical Oncology Congress? Make sure to stop by our two EACR-ESMO sessions on the 24th and 25th of October on the molecular basis of cancer. #ESMO26
Find session details here: https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal/session/list
@myesmo.bsky.socialAhead of #ESMO26 #CancerVaccines are generating global attention, but what questions still need answering before they can reshape #ClinicalPractice?
Read more in an interview with James Larkin, ESMO Congress 2026 Scientific Co-Chair đź”— https://ow.ly/F4CV50ZXEha
@onclive.bsky.socialWhat data are set to move the needle in gynecologic oncology care during #ESMO26? Experts break down some of the top abstracts to watch in Madrid #gynsm #ovca #oncology
Sign up and read more: www.onclive.com/view/long-te...
@icon-plc.bsky.socialDeveloping ADCs, radiopharmaceuticals and cell therapies brings specialised clinical and operational considerations. Discuss your development strategy with ICON experts at #ESMO26, booth #8005. Schedule a meeting: https://ow.ly/LQza50ZTnXR
@myesmo.bsky.socialDiscover the collaborations, initiatives and expert discussions shaping the present and future of oncology. From innovation to clinical practice, from policy to patient-centred care, these sessions highlight progress across the # CancerCare continuum.
@myesmo.bsky.socialđź’¬ #ESMOconversations: What #ProfessionalAdvice has stayed with you throughout your career?
Reflect on those conversations that helped shape your professional path. Share your story to inspire others and tag the people who shaped your #ProfessionalJourney. #ESMO26
@myesmo.bsky.socialThe ESMO-MCBS session at #ESMO26 explores clinical benefit assessment, novel trial endpoints and the role of evidence in informing access and reimbursement decisions. Mark it on your calendar.
@myesmo.bsky.socialFrom the costs of #CancerCare to barriers to #ClinicalTrials, from global cancer control to challenges in humanitarian settings, the Public Policy Track at #ESMO26 brings these critical discussions to the forefront.
👉Discover the programme:
https://ow.ly/VKMG50ZWK4C
@onclive.bsky.social
@tamedoncol.bsky.socialGet ready for #ESMO26 by revisiting the evolving treatment landscape of #SCLC with this review published on #TAMO in 2025.
From current standards to DLL3-targeted therapies, #ADCs and emerging biomarkers.
#Lungcancer
đź”— buff.ly/B2U9VpQ
@Roya_Behrouzi @fblackhall
@icon-plc.bsky.socialOncology biotechs need development strategies that can respond to rapid decisions and scale as programs advance. Meet the ICON Biotech and oncology experts at #ESMO26, booth #8005. Arrange a meeting: https://ow.ly/YOZG50ZTnXt
@oncoalert.bsky.socialThe OncoAlert #ESMO26 PULSE is ready 🇪🇸
As Madrid gets closer, your OncoAlert Network has gathered the faculty who will report live from ESMO and keep you up to date on the science out of Spain.
In the room or following from home, we've got you covered.
âś… Less noise
âś… No nonsense
âś… Just science
@salutedomani.bsky.socialTumore e IA: Insilico Medicine presenterà i primi dati sull’uomo dell’inibitore pan-TEAD ISM6331 a #ESMO26
Insilico Medicine, azienda di ricerca di farmaci basata sull'intelligenza artificiale generativa (IA) in fase clinica, ha ricordato oggi alla comunità oncologica che i dati iniziali della…
@axs-studio.com
